← SynDRA
SX-682
SynDRA canonical compound SYN0039626 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
| Primary target(s) | CXCL11 | CXCR1 | CXCR2 |
| Mechanism of action | antitumor agent |
| Indication | myeloproliferative neoplasms |
| Disease area | hematologic malignancy |
All known targets
Mechanisms of action (all sources)
- CXCR2 INHIBITOR
- Interleukin-8 receptors, CXCR1/CXCR2 inhibitor
- CXCR1 INHIBITOR
- antitumor agent
Cross-references
Synonyms
- SX682
- SX 682
- UNII-H5212R2DPM
- H5212R2DPM
- (2-(((5-((4-Fluorophenyl)carbamoyl)pyrimidin-2-yl)thio)methyl)-4-(trifluoromethoxy)phenyl)boronic acid
- CHEMBL4297480
- GTPL10165
- BCP32154
- EX-A4295
- MFCD28502254
- s8947
- SB17394
- HY-119339
- CS-0067128
- [2-[[5-[(4-fluorophenyl)carbamoyl]pyrimidin-2-yl]sulfanylmethyl]-4-(trifluoromethoxy)phenyl]boronic acid
- 2-(2-Dihydroxyboryl-5-trifluoromethoxybenzylsulfanyl)pyrimidine-5-carboxylic acid (4-fluorophenyl)amide
- B-(2-(((5-(((4-Fluorophenyl)amino)carbonyl)-2-pyrimidinyl)thio)methyl)-4-(trifluoromethoxy)phenyl)boronic acid
- Boronic acid, B-(2-(((5-(((4-fluorophenyl)amino)carbonyl)-2-pyrimidinyl)thio)methyl)-4-(trifluoromethoxy)phenyl)-
- RefChem:905751
- C19H14BF4N3O4S
- orb1298883
- SCHEMBL16436044
- SCHEMBL30515687
- SX 682 [WHO-DD]
- SDUDZBCEHIZMFZ-UHFFFAOYSA-N
- YQC84304
- AKOS040759427
- NCGC00842079-01
- AC-36549
- DA-67869
- SY328459
- TS-09812
- T8497
- D81536
- F797148
Look up SX-682 in the interactive SynDRA portal →